SARS-CoV-2 in Infants: Clinical Patterns, Laboratory Findings, and Implications for Pediatric Care in Viral Outbreaks

Marwh G Aldriwesh1,2,3, Norah F Abukhalid1,2,3, Sarah M Alotaibi1,2,3

  • 1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Insights

COVID-19 in infants is generally mild, but younger infants (under 6 months) show increased vulnerability. This study highlights age-specific differences in symptoms and lab findings, emphasizing tailored care for pediatric COVID-19 patients.

Area of Science:

  • Pediatric infectious diseases
  • Viral pathogenesis in infants
  • Public health and epidemiology

Background:

  • COVID-19 (Coronavirus disease 2019) has significantly impacted global healthcare systems.
  • While adult COVID-19 presentations are documented, data on infant infections, especially by age group, remain limited.

Purpose of the Study:

  • To compare the clinical presentation, laboratory findings, and outcomes of infants diagnosed with COVID-19.
  • To differentiate between infants aged 6 months or younger and those older than 6 months.

Main Methods:

  • A retrospective cross-sectional study was conducted at a tertiary pediatric hospital in Saudi Arabia.
  • Electronic medical records of 388 infants with confirmed COVID-19 (March 2020-December 2022) were analyzed.
  • Demographic, clinical, laboratory, and outcome data were compared between infants aged ⩽6 months and >6 months.

Main Results:

  • Infants aged ⩽6 months constituted 54.6% of the cohort. Fever, cough, and rhinorrhea were common symptoms.
  • Diarrhea was more frequent in infants >6 months (58.6% vs. 41.4%).
  • White blood cell abnormalities varied by age, with leukopenia in younger infants and leukocytosis in older infants. Mortality was low (1.03%), affecting primarily infants ⩽3 months with comorbidities.

Conclusions:

  • SARS-CoV-2 infection in infants is typically mild with low mortality.
  • Infants aged ⩽6 months exhibited greater clinical vulnerability compared to older infants.
  • Findings support age-specific risk assessment and management strategies for pediatric COVID-19 cases.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...